Recurrent atypical bronchial tumor diagnosed as small cell lung cancer
Zych, J.; Słodkowska, J.; Burakowska, B.
Pneumonologia i Alergologia Polska 63(1-2): 72-76
1995
ISSN/ISBN: 0867-7077 PMID: 7633373 Document Number: 440131
The case of atypical carcinoid was presented. 5 years after resection of mediastinal mass, the tumor in main left bronchus developed and the diagnosis of small cell lung cancer was established. The pathological analysis of previous slides from resected tumour and bronchial biopsy showed the same atypical carcinoid. The patient was successfully treated using chemotherapy.
Document emailed within 1 workday
Related Documents
Matturri, L.; Lavezzi, A.M. 1994: Recurrent chromosome alterations in non-small cell lung cancer European Journal of Histochemistry: Ejh 38(1): 53-58Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Hirose, T.; Hosaka, T.; Nakashima, M.; Sugiyama, T.; Ishida, H.; Yamaoka, T.; Okuda, K.; Adachi, M. 2008: Two cases with recurrent non-small cell lung cancer successfully treated with cisplatin and S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(2): 327-330
Tüzün, E.; Yaka, E.; Zuliani, L.; Içöz, S.; Baklan, B.ş; Birişik, O.; Kurd, P.; Akman-Demir, G.ül.şe.; Vincent, A.; Akdal, G.ül. 2011: Steroid-responsive recurrent limbic encephalitis associated with small cell lung cancer and neuropil antibodies Acta Neurologica Belgica 111(2): 139-142
Kaira, K.; Ishizuka, T.; Yanagitani, N.; Sunaga, N.; Hisada, T.; Mori, M. 2007: Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 225-227
Hu, M.; Kong, L.; Zhao, S.-Q.; Yang, G.-R.; Yang, W.-F.; Han, A.-Q.; Fu, Z.; Ma, L.; Zheng, J.-S.; Yu, J.-M. 2010: Value of 18F-FETNIM PET-CT for detection of tumor hypoxia in non-small-cell lung cancer Zhonghua Zhong Liu Za Zhi 32(6): 463-466
Shimizu, M.; Miya, T.; Takahashi, A.; Kobayashi, Y.; Kubota, K.; Gemma, A.; Hirose, T. 2017: Nearly Complete Response after Second-Line Therapy with Nab-Paclitaxel Monotherapy in a Patient with Recurrent Advanced Non-Small Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(8): 699-702
You, J.; Yu, J-pu.; Ren, X-bao.; Wang, C-li.; Zhang, P.; Zhang, X-zeng. 2004: Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 26(6): 333-336
Huang, M.S.; Jong, S.B.; Lin, M.S.; Chong, I.W.; Tsai, M.S.; Lin, H.C.; Hwang, J.J. 1996: Cytokeratin fragment 19 (CYFRA 21-1) as a tumor marker in non-small cell lung cancer Kaohsiung Journal of Medical Sciences 12(2): 62-68
Mori, A.; Hirose, T.; Tamura, A.; Kusaka, K.; Matsui, H.; Ohta, K. 2016: Evaluation of the Efficacy and Safety of Platinum Doublet Re-Challenge Chemotherapy in Patients with Recurrent Advanced Non-Small Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(6): 723-726
Eskenasy, A. 1986: The microcellular (oat cell, small cell anaplastic) carcinoma of the lung. A histopathological study of 620 diagnosed cases Morphologie et Embryologie 32(4): 257-269
Qu, Y.-m.; Liao, G.-q.; Liu, P.-h.; Wang, H.-m.; Liu, L.; Li, L.-l.; Xie, G.-q. 2010: Clinical significance of expressions of tumor markers in peripheral blood in non-small cell lung cancer Zhonghua Yi Xue Za Zhi 90(28): 1958-1962
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Chen, W.-h.; Wang, C.; Zhang, Y.-h.; Yang, Y.-h.; Zhan, H.-y.; Zhang, L.-m. 2007: Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer Zhonghua Yi Xue Za Zhi 87(45): 3228-3232
Yang, S.C.; Owen-Schaub, L.; Mendiguren-Rodriguez, A.; Grimm, E.A.; Hong, W.K.; Roth, J.A. 1990: Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha Journal of Thoracic and Cardiovascular Surgery 99(1): 8
Schalhorn, A. 1985: Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer Fortschritte der Medizin 103(17): 453-456
Wang, Y-jie.; Wang, Lü-hua.; Lü, J-ma.; Zhao, L-jun.; Xiao, Z-fen.; Zhang, H-xing.; Feng, Q-fu.; Zhang, Z.; Yin, W-bo. 2006: Three-dimensional conformal radiotherapy for locoregionally recurrent non-small cell lung cancer after initial radiotherapy Zhonghua Zhong Liu Za Zhi 28(3): 227-229
De Granda Orive, J.I.; Ramírez Garćia, J.R.; Martínez Albiach, J.M.; Enrech Francés, S.; Escobar Sacristán, J.A.; Herrera de la Rosa, A. 1997: Pleural effusion with diffuse lung involvement and single subcutaneous nodule as first manifestation of atypical bronchial carcinoid tumor Anales de Medicina Interna 14(6): 299-301
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Shen, H.-C.; Wang, X.-W.; Liu, Y.-G. 2008: Tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer: experiment with mice Zhonghua Yi Xue Za Zhi 88(35): 2498-2503